In a hemodynamically stable patient with new‑onset atrial fibrillation and a resting heart rate of 112 bpm presenting only with palpitations, should I use sotalol or metoprolol for treatment, and is hospitalization required?

Metoprolol for Rate Control; Hospitalization NOT Required for Sotalol Initiation

For a hemodynamically stable patient with new-onset atrial fibrillation, HR 112 bpm, and only palpitations, use metoprolol (or another beta-blocker) for initial rate control. Hospitalization is NOT required for this clinical scenario, though if sotalol is chosen for rhythm control purposes, mandatory inpatient monitoring for 3+ days is required per FDA labeling.

Rate Control Strategy

Initial Management

Your patient meets criteria for lenient rate control with a target resting heart rate <110 bpm 1. Since the current HR is 112 bpm with only palpitations and hemodynamic stability, this is not an emergency requiring immediate aggressive intervention.

Beta-blockers (metoprolol, atenolol) are first-line agents for rate control in patients with preserved left ventricular function (LVEF >40%) 1. These medications:

• Provide effective rate control at rest and during activity
• Are safe for outpatient initiation
• Do not require continuous ECG monitoring for initiation
• Are recommended as Class I, Level B evidence 1

Why NOT Sotalol for This Scenario

Sotalol requires mandatory hospitalization with continuous ECG monitoring for a minimum of 3 days (or 5-6 doses if dosed once daily) 2. The FDA labeling is explicit:

• Baseline QTc must be ≤450 msec before first dose
• Creatinine clearance must be calculated and documented
• Continuous telemetry monitoring required with QT measurements 2-4 hours after each dose
• If QTc reaches ≥500 msec, the drug must be discontinued 2
• Risk of Torsade de Pointes (life-threatening ventricular arrhythmia) occurs in 0.6% of AF patients, with higher risk at doses >320 mg/day 2

Practical Algorithm

For outpatient management (your patient):

1. Start metoprolol 25-50 mg PO twice daily (or metoprolol succinate 50-100 mg daily)
2. Target resting HR <110 bpm initially 1
3. If symptoms persist despite HR <110, consider stricter control (80-90 bpm at rest)
4. Reassess in 1-2 weeks with repeat ECG and symptom assessment

If sotalol were considered (for rhythm control, not just rate control):

1. Admit to telemetry unit
2. Calculate creatinine clearance
3. Check baseline QTc (must be ≤450 msec)
4. Start 80 mg BID (if CrCl >60) or 80 mg daily (if CrCl 40-60)
5. Monitor QTc 2-4 hours after each dose for minimum 3 days
6. Discharge only if QTc remains <500 msec 2

Key Clinical Distinctions

Rate vs. Rhythm Control

The 2024 ESC guidelines 1 support rate control as initial therapy in the acute setting. Your patient's presentation (stable, HR 112, palpitations only) does not mandate immediate rhythm control or cardioversion.

Metoprolol provides:

• Rapid rate control (within hours)
• Safe outpatient initiation
• Effective symptom relief for palpitations
• No proarrhythmic risk

Sotalol is primarily a rhythm control agent with rate-controlling properties. Research shows sotalol provides superior rate control compared to metoprolol during submaximal exercise 3, but this advantage does not justify the mandatory hospitalization requirement for a stable patient with mild symptoms.

Common Pitfalls to Avoid

1. Do not confuse rate control with rhythm control needs: This patient needs rate control for symptom management, not urgent rhythm control
2. Do not initiate sotalol outpatient: The FDA mandates inpatient monitoring regardless of how "stable" the patient appears 2
3. Do not over-treat the heart rate: HR of 112 is only marginally above the lenient target of <110 bpm 1
4. Ensure anticoagulation assessment: All AF patients require stroke risk stratification (CHA₂DS₂-VASc score) regardless of rate vs. rhythm control strategy 1

When Hospitalization IS Indicated

Admit for:

• Hemodynamic instability (hypotension, pulmonary edema, chest pain)
• HR persistently >130-140 despite initial treatment
• Concern for acute coronary syndrome or other precipitating illness
• If choosing sotalol for rhythm control (mandatory per FDA) 2
• Suspicion of tachycardia-induced cardiomyopathy

Your patient with HR 112 and only palpitations does not meet these criteria.